369 related articles for article (PubMed ID: 15220345)
1. Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway.
Choi YA; Lim HK; Kim JR; Lee CH; Kim YJ; Kang SS; Baek SH
J Biol Chem; 2004 Aug; 279(35):36579-85. PubMed ID: 15220345
[TBL] [Abstract][Full Text] [Related]
2. Akt as a mediator of secretory phospholipase A2 receptor-involved inducible nitric oxide synthase expression.
Park DW; Kim JR; Kim SY; Sonn JK; Bang OS; Kang SS; Kim JH; Baek SH
J Immunol; 2003 Feb; 170(4):2093-9. PubMed ID: 12574380
[TBL] [Abstract][Full Text] [Related]
3. Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signalling pathways, Akt and Erk.
Ruhul Amin AR; Senga T; Oo ML; Thant AA; Hamaguchi M
Genes Cells; 2003 Jun; 8(6):515-23. PubMed ID: 12786942
[TBL] [Abstract][Full Text] [Related]
4. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
[TBL] [Abstract][Full Text] [Related]
5. Scalaradial inhibition of epidermal growth factor receptor-mediated Akt phosphorylation is independent of secretory phospholipase A2.
Xie Y; Liu L; Huang X; Guo Y; Lou L
J Pharmacol Exp Ther; 2005 Sep; 314(3):1210-7. PubMed ID: 15923342
[TBL] [Abstract][Full Text] [Related]
6. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
7. Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration.
Takino T; Miyamori H; Watanabe Y; Yoshioka K; Seiki M; Sato H
Cancer Res; 2004 Feb; 64(3):1044-9. PubMed ID: 14871836
[TBL] [Abstract][Full Text] [Related]
8. EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways.
Qiu Q; Yang M; Tsang BK; Gruslin A
Reproduction; 2004 Sep; 128(3):355-63. PubMed ID: 15333786
[TBL] [Abstract][Full Text] [Related]
9. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
Zhang D; Brodt P
Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384
[TBL] [Abstract][Full Text] [Related]
10. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases.
Miyamori H; Takino T; Kobayashi Y; Tokai H; Itoh Y; Seiki M; Sato H
J Biol Chem; 2001 Jul; 276(30):28204-11. PubMed ID: 11382769
[TBL] [Abstract][Full Text] [Related]
11. Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism.
D'Alessio S; Ferrari G; Cinnante K; Scheerer W; Galloway AC; Roses DF; Rozanov DV; Remacle AG; Oh ES; Shiryaev SA; Strongin AY; Pintucci G; Mignatti P
J Biol Chem; 2008 Jan; 283(1):87-99. PubMed ID: 17991754
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis.
Munshi HG; Wu YI; Mukhopadhyay S; Ottaviano AJ; Sassano A; Koblinski JE; Platanias LC; Stack MS
J Biol Chem; 2004 Sep; 279(37):39042-50. PubMed ID: 15247230
[TBL] [Abstract][Full Text] [Related]
13. TIMP-2 Interaction with MT1-MMP Activates the AKT Pathway and Protects Tumor Cells from Apoptosis.
Valacca C; Tassone E; Mignatti P
PLoS One; 2015; 10(9):e0136797. PubMed ID: 26331622
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol-3 kinase-dependent activation of Akt does not correlate with either high mitogenicity or cell migration induced by FGF-1.
Marcinkowska E; Wiedlocha A
Anticancer Res; 2003; 23(5A):4071-7. PubMed ID: 14666721
[TBL] [Abstract][Full Text] [Related]
16. Nerve growth factor induces endothelial cell invasion and cord formation by promoting matrix metalloproteinase-2 expression through the phosphatidylinositol 3-kinase/Akt signaling pathway and AP-2 transcription factor.
Park MJ; Kwak HJ; Lee HC; Yoo DH; Park IC; Kim MS; Lee SH; Rhee CH; Hong SI
J Biol Chem; 2007 Oct; 282(42):30485-96. PubMed ID: 17666398
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways.
Onodera S; Nishihira J; Iwabuchi K; Koyama Y; Yoshida K; Tanaka S; Minami A
J Biol Chem; 2002 Mar; 277(10):7865-74. PubMed ID: 11751895
[TBL] [Abstract][Full Text] [Related]
18. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
Jo Y; Yeon J; Kim HJ; Lee ST
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
[TBL] [Abstract][Full Text] [Related]
19. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
Bernardo MM; Fridman R
Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
[TBL] [Abstract][Full Text] [Related]
20. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.
Hofmann UB; Westphal JR; Van Kraats AA; Ruiter DJ; Van Muijen GN
Int J Cancer; 2000 Jul; 87(1):12-9. PubMed ID: 10861447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
